Michael Salacz
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
- Genetics 12
- Glioma Diagnosis and Treatment 11
-
- Epigenetics and DNA Methylation 2
- Histone Deacetylase Inhibitors Research 2
- Co-authors
- Peggy Ward‐Smith (1 shared paper)David A. Reardon (3 shared papers)Christine Hicking (1 shared paper)Debra K. Newman (1 shared paper)Tom Mikkelsen (1 shared paper)Monika E. Hegi (1 shared paper)Brian Boylan (1 shared paper)Mark L. Kahn (1 shared paper)
- Journals
- Neuro-Oncology (4 papers)Journal of Palliative Medicine (3 papers)Journal of Clinical Oncology (2 papers)OncoTargets and Therapy (1 paper)Blood (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Michael Salacz
17 papers receiving 481 citations
Peers
Comparison fields: 5 of 68
- Genetics 155
- Immunology and Allergy 69
- Hematology 128
- Cancer Research 54
- Oncology 90
Countries citing papers authored by Michael Salacz
This map shows the geographic impact of Michael Salacz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Salacz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Salacz more than expected).
Fields of papers citing papers by Michael Salacz
This network shows the impact of papers produced by Michael Salacz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Salacz. The network helps show where Michael Salacz may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Salacz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 187 | |
| 2 | 2004 | 123 | |
| 3 | 2008 | 65 | |
| 4 | 2016 | 29 | |
| 5 | Glioblastoma: Part I. Current state of affairs. | 2011 | 14 |
| 6 | 2022 | 12 | |
| 7 | 2007 | 12 | |
| 8 | 2008 | 12 | |
| 9 | 2016 | 10 | |
| 10 | 2005 | 10 | |
| 11 | 2006 | 8 | |
| 12 | 2018 | 7 | |
| 13 | Glioblastoma. Part II: Future directions. | 2011 | 6 |
| 14 | 2017 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2017 | 3 | |
| 17 | 2017 | 1 | |
| 18 | 2018 | 0 | |
| 19 | 2018 | 0 | |
| 20 | 2008 | 0 |
About Michael Salacz
Michael Salacz is a scholar working on Genetics, Molecular Biology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Cancer Research, having authored 20 papers that have together received 508 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (11 papers), Cancer, Hypoxia, and Metabolism (3 papers), Neuroblastoma Research and Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Brain Metastases and Treatment (2 papers), Cancer Research and Treatments (2 papers) and Palliative Care and End-of-Life Issues (2 papers). The work is most often cited by research in Genetics (155 citations), Immunology and Allergy (69 citations), Hematology (128 citations), Cancer Research (54 citations) and Oncology (90 citations). Michael Salacz has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Peggy Ward‐Smith, David A. Reardon, Christine Hicking, Debra K. Newman, Tom Mikkelsen, Monika E. Hegi, Brian Boylan, Mark L. Kahn, Peter J. Newman and Kenneth D. Friedman. Their work appears in journals such as Neuro-Oncology, Journal of Palliative Medicine, Journal of Clinical Oncology, OncoTargets and Therapy and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.